Image source: The Motley Fool.
Kura Oncology, inc (NASDAQ: KURA)
Q3 2021 Earnings Call
Nov 4, 2021 , 4:30 p.m. ET
Operator
For further details see:
Kura Oncology, inc (KURA) Q3 2021 Earnings Call TranscriptImage source: The Motley Fool.
Kura Oncology, inc (NASDAQ: KURA)
Q3 2021 Earnings Call
Nov 4, 2021 , 4:30 p.m. ET
Operator
For further details see:
Kura Oncology, inc (KURA) Q3 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-06-25 22:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-25 08:15:04 ET H.C. Wainwright analyst issues BUY recommendation for KURA on June 25, 2024 06:44AM ET. The previous analyst recommendation was Buy. KURA was trading at $21.08 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
– Ziftomenib induces insulin production, improves insulin sensitivity and reduces insulin resistance in preclinical model of type 2 diabetes – – Kura advancing multiple, next-generation menin inhibitor drug candidates targeting diabetes and other metabolic diseases ...